RNF40 epigenetically modulates glycolysis to support the aggressiveness of basal-like breast cancer.


Journal

Cell death & disease
ISSN: 2041-4889
Titre abrégé: Cell Death Dis
Pays: England
ID NLM: 101524092

Informations de publication

Date de publication:
28 09 2023
Historique:
received: 05 12 2022
accepted: 15 09 2023
revised: 06 09 2023
medline: 2 10 2023
pubmed: 29 9 2023
entrez: 28 9 2023
Statut: epublish

Résumé

Triple-negative breast cancer (TNBC) is the most difficult breast cancer subtype to treat due to the lack of targeted therapies. Cancer stem cells (CSCs) are strongly enriched in TNBC lesions and are responsible for the rapid development of chemotherapy resistance and metastasis. Ubiquitin-based epigenetic circuits are heavily exploited by CSCs to regulate gene transcription and ultimately sustain their aggressive behavior. Therefore, therapeutic targeting of these ubiquitin-driven dependencies may reprogram the transcription of CSC and render them more sensitive to standard therapies. In this work, we identified the Ring Finger Protein 40 (RNF40) monoubiquitinating histone 2B at lysine 120 (H2Bub1) as an indispensable E3 ligase for sustaining the stem-cell-like features of the growing mammary gland. In addition, we found that the RNF40/H2Bub1-axis promotes the CSC properties and drug-tolerant state by supporting the glycolytic program and promoting pro-tumorigenic YAP1-signaling in TNBC. Collectively, this study unveils a novel tumor-supportive role of RNF40 and underpins its high therapeutic value to combat the malignant behavior of TNBC.

Identifiants

pubmed: 37770435
doi: 10.1038/s41419-023-06157-5
pii: 10.1038/s41419-023-06157-5
pmc: PMC10539310
doi:

Substances chimiques

Histones 0
Ubiquitin-Protein Ligases EC 2.3.2.27
Ubiquitins 0
RNF40 protein, human EC 2.3.2.27

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

641

Informations de copyright

© 2023. The Author(s).

Références

Mol Cell. 2012 Jun 8;46(5):705-13
pubmed: 22681891
PLoS Genet. 2015 Aug 21;11(8):e1005465
pubmed: 26295846
Cell. 2006 May 19;125(4):703-17
pubmed: 16713563
FEBS Lett. 2012 Jun 4;586(11):1592-601
pubmed: 22564770
Stem Cells. 2014 Jul;32(7):1734-45
pubmed: 24497069
Curr Opin Struct Biol. 2019 Dec;59:98-106
pubmed: 31229920
Front Physiol. 2022 Mar 16;13:826107
pubmed: 35399282
Nat Rev Dis Primers. 2019 Sep 23;5(1):66
pubmed: 31548545
Br J Cancer. 2021 Feb;124(3):604-615
pubmed: 33139797
Sci Rep. 2020 Nov 18;10(1):20044
pubmed: 33208877
Oncogene. 2022 Feb;41(8):1129-1139
pubmed: 35046531
Cells. 2019 Aug 22;8(9):
pubmed: 31443516
Genome Res. 2014 Oct;24(10):1572-83
pubmed: 25049226
Cell Metab. 2011 Aug 3;14(2):264-71
pubmed: 21803296
Proc Natl Acad Sci U S A. 2003 Dec 9;100(25):14725-30
pubmed: 14630949
Endocr Relat Cancer. 2020 Apr;27(4):221-230
pubmed: 32023208
Biosci Rep. 2018 Jul 12;38(4):
pubmed: 29934362
Genes (Basel). 2019 Jan 18;10(1):
pubmed: 30669413
Cell. 2019 Mar 7;176(6):1490-1501.e12
pubmed: 30765112
Endocr Relat Cancer. 2015 Feb;22(1):T19-33
pubmed: 24891457
Nat Med. 2018 Oct;24(10):1599-1610
pubmed: 30224758
Nat Cell Biol. 2008 Apr;10(4):483-8
pubmed: 18344985
Int J Cancer. 2021 Jun 15;148(12):2884-2897
pubmed: 33197277
Nat Cell Biol. 2021 Nov;23(11):1187-1198
pubmed: 34737445
J Mammary Gland Biol Neoplasia. 2012 Jun;17(2):111-7
pubmed: 22665270
Exp Mol Med. 2016 Apr 01;48:e224
pubmed: 27034026
Cancer Res. 2011 Sep 1;71(17):5739-53
pubmed: 21862633
Cell Death Differ. 2017 Apr;24(4):694-704
pubmed: 28157208
Front Pharmacol. 2021 Apr 15;12:645864
pubmed: 33935743
Genome Biol. 2014;15(12):550
pubmed: 25516281
Cell Rep. 2017 Jul 25;20(4):909-922
pubmed: 28746875
Acta Pharm Sin B. 2022 Mar;12(3):1271-1287
pubmed: 35530161
Oncogene. 2021 Jan;40(3):465-474
pubmed: 33199825
J Crohns Colitis. 2019 Mar 26;13(3):362-373
pubmed: 30321325
Nat Commun. 2021 May 24;12(1):3055
pubmed: 34031411
CA Cancer J Clin. 2021 May;71(3):209-249
pubmed: 33538338
Proc Natl Acad Sci U S A. 2020 Apr 7;117(14):8013-8021
pubmed: 32193335
Genome Res. 2012 Jun;22(6):1026-35
pubmed: 22421545
Stem Cell Reports. 2013 Dec 27;2(1):78-91
pubmed: 24511467
Cell Death Dis. 2021 Nov 29;12(12):1118
pubmed: 34845197
Cell Death Dis. 2020 Oct 17;11(10):873
pubmed: 33070155
Bioessays. 2020 May;42(5):e1900162
pubmed: 32128850
Nucleic Acids Res. 2020 Jul 27;48(13):7154-7168
pubmed: 32496538
Clin Epigenetics. 2019 Jul 2;11(1):98
pubmed: 31266541
Cell Res. 2011 Mar;21(3):381-95
pubmed: 21321607
Bull Cancer. 2021 Apr;108(4):385-398
pubmed: 33685627
Methods Mol Biol. 2021;2191:261-285
pubmed: 32865750
Cancer J. 2010 Jan-Feb;16(1):12-6
pubmed: 20164685
Mol Cell Endocrinol. 2012 Mar 5;350(1):87-98
pubmed: 22155569
Cell Metab. 2018 Aug 7;28(2):196-206
pubmed: 30089241
Cell. 2009 May 1;137(3):459-71
pubmed: 19410543
Proc Natl Acad Sci U S A. 2014 Sep 16;111(37):13367-72
pubmed: 25187560
Nat Rev Mol Cell Biol. 2014 Apr;15(4):243-56
pubmed: 24651542
Cell Rep. 2014 Oct 23;9(2):495-503
pubmed: 25373897
Cancer Drug Resist. 2021 Jun 19;4(2):321-342
pubmed: 35582030
Oncogene. 2021 Jun;40(23):4004-4018
pubmed: 34007022
Cancer Discov. 2013 Aug;3(8):880-93
pubmed: 23661552
Mol Cell. 2019 Aug 22;75(4):683-699.e7
pubmed: 31399344
Cancers (Basel). 2020 Jul 24;12(8):
pubmed: 32722184
PLoS One. 2019 Mar 15;14(3):e0209392
pubmed: 30875375
Mol Cell. 2014 Jun 19;54(6):920-931
pubmed: 24837678
PLoS One. 2012;7(5):e36775
pubmed: 22615809
Bioinformatics. 2009 May 1;25(9):1105-11
pubmed: 19289445
Mol Cell. 2003 Jan;11(1):261-6
pubmed: 12535538
Cancers (Basel). 2022 Feb 16;14(4):
pubmed: 35205738
Hum Mol Genet. 2016 Dec 15;25(24):5460-5471
pubmed: 27798111
Stem Cells. 2021 Feb;39(2):133-143
pubmed: 33211379
Adv Cancer Res. 2020;148:1-26
pubmed: 32723561
Anticancer Res. 2017 May;37(5):2173-2183
pubmed: 28476780
Nat Commun. 2015 Apr 28;6:7049
pubmed: 25916810
Cells. 2022 Aug 04;11(15):
pubmed: 35954248
Curr Protoc Bioinformatics. 2015 Sep 03;51:11.14.1-11.14.19
pubmed: 26334920
Nat Genet. 2021 Sep;53(9):1334-1347
pubmed: 34493872
Cell Death Dis. 2020 Apr 27;11(4):287
pubmed: 32341358
Sci Rep. 2018 Nov 13;8(1):16743
pubmed: 30425310
Genome Biol. 2017 Feb 16;18(1):32
pubmed: 28209164
Proc Natl Acad Sci U S A. 2017 Mar 21;114(12):E2337-E2346
pubmed: 28270621
Mol Cell. 2005 Nov 23;20(4):601-11
pubmed: 16307923
Mol Cell Biol. 2019 Apr 2;39(8):
pubmed: 30692271
Cell Death Dis. 2020 Feb 3;11(2):89
pubmed: 32015333
Cell Death Dis. 2014 Jul 17;5:e1336
pubmed: 25032859

Auteurs

Evangelos Prokakis (E)

Department of Gynecology and Obstetrics, University Medical Center Göttingen, Göttingen, Germany. eprokak@gwdg.de.
Department of General, Visceral & Pediatric Surgery, University Medical Center Göttingen, Göttingen, Germany. eprokak@gwdg.de.

Shaishavi Jansari (S)

Department of Gynecology and Obstetrics, University Medical Center Göttingen, Göttingen, Germany.

Angela Boshnakovska (A)

Department of Cellular Biochemistry, University Medical Center Göttingen, Göttingen, Germany.

Maria Wiese (M)

Department of Pediatrics and Adolescent Medicine, Division of Pediatric Hematology and Oncology, University Medical Center Göttingen, Göttingen, Germany.

Kathrin Kusch (K)

Institute for Auditory Neuroscience, Functional Auditory Genomics Group, University Medical Center Göttingen, Göttingen, Germany.

Christof Kramm (C)

Department of Pediatrics and Adolescent Medicine, Division of Pediatric Hematology and Oncology, University Medical Center Göttingen, Göttingen, Germany.

Christian Dullin (C)

Institute for Diagnostic and Interventional Radiology, University Medical Center Göttingen, Göttingen, Germany.
Department of Diagnostic and Interventional Radiology, University Hospital Heidelberg, Heidelberg, Germany.
Max Planck Institute for Multidisciplinary Sciences, Göttingen, Germany.

Peter Rehling (P)

Department of Cellular Biochemistry, University Medical Center Göttingen, Göttingen, Germany.

Markus Glatzel (M)

Institute of Neuropathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Klaus Pantel (K)

Institute of Tumor Biology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Harriet Wikman (H)

Institute of Tumor Biology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Steven A Johnsen (SA)

Department of General, Visceral & Pediatric Surgery, University Medical Center Göttingen, Göttingen, Germany.
The Robert Bosch Center for Tumor Diseases, Stuttgart, Germany.

Julia Gallwas (J)

Department of Gynecology and Obstetrics, University Medical Center Göttingen, Göttingen, Germany.

Florian Wegwitz (F)

Department of Gynecology and Obstetrics, University Medical Center Göttingen, Göttingen, Germany. fwegwit@gwdg.de.
Department of General, Visceral & Pediatric Surgery, University Medical Center Göttingen, Göttingen, Germany. fwegwit@gwdg.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH